Loss-of-function mutations in the solute carrier organic anion transporter family, member 2a1 gene (SLCO2A1), which encodes a prostaglandin (PG) transporter, have been identified as causes of chronic nonspecific multiple ulcers in the small intestine; however, the underlying mechanisms have not been revealed. We, therefore, evaluated the effects of systemic knockout of Slco2a1 (Slco2a1 −/−) and conditional knockout in intestinal epithelial cells (Slco2a1 ΔIEC) and macrophages (Slco2a1 ΔMP) in mice with dextran sodium sulphate (DSS)-induced acute colitis. Slco2a −/− mice were more susceptible to DSS-induced colitis than wild-type (WT) mice, but did not spontaneously develop enteritis or colitis. The nucleotide-binding domain, leucine-rich repeats containing family, pyrin domain-containing-3 (NLRP3) inflammasome was more strongly upregulated in colon tissues of Slco2a −/− mice administered DSS and in macrophages isolated from Slco2a1 −/− mice than in the WT counterparts. Slco2a1 ΔMP , but not Slco2a1 ΔIEC mice, were more susceptible to DSS-induced colitis than WT mice, partly phenocopying Slco2a −/− mice. Concentrations of PGE 2 in colon tissues and macrophages from Slco2a1 −/− mice were significantly higher than those of WT mice. Blockade of inflammasome activation suppressed the exacerbation of colitis. These results indicated that Slco2a1-deficiency increases the PGE 2 concentration, resulting in NLRP3 inflammasome activation in macrophages, thus exacerbating intestinal inflammation. Prostaglandin (PG) E 2 is the most physiologically abundant eicosanoid biosynthesized from arachidonic acid by cyclooxygenase (COX). PGE 2 has important roles in maintaining gut mucosal homeostasis 1,2 , but also is an essential mediator of the immune response and inflammation in various inflammatory diseases 3. Indeed, small intestinal ulcers can be induced by nonsteroidal anti-inflammatory drugs (NSAIDs) treatment through suppressing PGE 2 synthesis by inhibition of COX. PGE 2 is exported to the extracellular microenvironment by multiple drug resistance-associated protein 4 (MRP4/ABCC4) 4 and exerts its effects by binding to a family of G protein-coupled receptors consisting of four subtypes: EP1, EP2, EP3, and EP4 5. Prostaglandin transporter (PGT), encoded by the solute carrier organic anion transporter family, member 2a1 gene (SLCO2A1) mediates cellular uptake of PGE 2 6,7. PGE 2 is oxidized intracellularly by 15-ketoprostaglandin dehydrogenase (15-PGDH; encoded by HPGD) 8,9. Thus, PGT plays an important role in PGE 2 metabolism. Umeno et al. recently reported that chronic enteropathy, which